Menu

Latest Rhinomed NEWS

RHINOMED COMPLETES AUD$3.6 MILLION CAPITAL RAISING

 

November 29th, 2017. Melbourne Australia
Rhinomed Limited (ASX: RNO or “the Company”) a leading sleep and nasal respiratory technology company has successfully undertaken an AUD$3.6 million placement to institutional and sophisticated private investors at $0.15 per share.

Read a full copy of the announcement here.